Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1993 Jun 26;306(6894):1707. doi: 10.1136/bmj.306.6894.1707

How can doctors diagnose colorectal cancer earlier?

I Maclennan, J Hill
PMCID: PMC1678313  PMID: 8343625

Full text

PDF

Page 1707

1707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cunliffe W. J., Hasleton P. S., Tweedle D. E., Schofield P. F. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg. 1984 Dec;71(12):941–943. doi: 10.1002/bjs.1800711210. [DOI] [PubMed] [Google Scholar]
  2. Donald I. P., FitzGerald Frazer J. S., Wilkinson S. P. Sigmoidoscopy/proctoscopy service with open access to general practitioners. Br Med J (Clin Res Ed) 1985 Mar 9;290(6470):759–761. doi: 10.1136/bmj.290.6470.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Houlston R. S., Murday V., Harocopos C., Williams C. B., Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ. 1990 Aug 18;301(6748):366–368. doi: 10.1136/bmj.301.6748.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kewenter J., Björk S., Haglind E., Smith L., Svanvik J., Ahrén C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988 Aug 1;62(3):645–651. doi: 10.1002/1097-0142(19880801)62:3<645::aid-cncr2820620333>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Kronborg O., Fenger C., Søndergaard O., Pedersen K. M., Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987 Aug;22(6):677–686. doi: 10.3109/00365528709011142. [DOI] [PubMed] [Google Scholar]
  6. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983 Jul 16;2(8342):149–152. doi: 10.1016/s0140-6736(83)90129-0. [DOI] [PubMed] [Google Scholar]
  7. Luchtefeld M. A., Ross D. S., Zander J. D., Folse J. R. Late development of metachronous colorectal cancer. Dis Colon Rectum. 1987 Mar;30(3):180–184. doi: 10.1007/BF02554334. [DOI] [PubMed] [Google Scholar]
  8. Lynch H. T., Lanspa S. J., Boman B. M., Smyrk T., Watson P., Lynch J. F., Lynch P. M., Cristofaro G., Bufo P., Tauro A. V. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. Gastroenterol Clin North Am. 1988 Dec;17(4):679–712. [PubMed] [Google Scholar]
  9. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  10. Morton D. G., Macdonald F., Haydon J., Cullen R., Barker G., Hultén M., Neoptolemos J. P., Keighley M. R., McKeown C. Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg. 1993 Feb;80(2):255–258. doi: 10.1002/bjs.1800800249. [DOI] [PubMed] [Google Scholar]
  11. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Lancet. 1989 Jan 7;1(8628):1–6. [PubMed] [Google Scholar]
  12. Phillips R. K., Hittinger R., Fry J. S., Fielding L. P. Malignant large bowel obstruction. Br J Surg. 1985 Apr;72(4):296–302. doi: 10.1002/bjs.1800720417. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES